Neuraxis (NRXS) Treasury Shares (2024 - 2026)
Neuraxis (NRXS) posted Treasury Shares of $1.3 million for Q1 2026, up 52.22% sequentially from $831346.0 in Q4 2025, and up 48.49% YoY from $852214.0 in Q1 2025.
Neuraxis (NRXS) Treasury Shares (2024 - 2026) Analysis & Trends
Neuraxis has reported Treasury Shares for 3 years, with the latest figure at $1.3 million in Q1 2026.
- Quarterly Treasury Shares rose 48.49% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 48.49% YoY) and the FY2025 annual result came in at $831346.0, changed N/A from the prior year.
- Treasury Shares climbed to $1.3 million in Q1 2026 per NRXS's latest filing, from $831346.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $2.1 million in Q3 2024 and troughed at $831346.0 in Q3 2025.
- A 3-year average of $1.1 million and a median of $852214.0 in 2025 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2025 and 2026: Treasury Shares tumbled 59.91% in 2025, then jumped 48.49% in 2026.
- Over 3 years, Treasury Shares stood at $2.1 million in 2024, then sank by 59.91% to $831346.0 in 2025, then surged by 52.22% to $1.3 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $1.3 million, $831346.0, and $831346.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Neuraxis | 74.54 Mn | 66.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Jun 30, 2026 | 1.27 Mn |
| Mar 31, 2026 | 1.27 Mn |
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | 831,346.00 |
| Dec 31, 2025 | 831,346.00 |
| Sep 30, 2025 | 831,346.00 |
| Sep 30, 2025 | 831,346.00 |
| Jun 30, 2025 | 852,214.00 |
| Jun 30, 2025 | 852,214.00 |
| Mar 31, 2025 | 852,214.00 |
| Mar 31, 2025 | 852,214.00 |
| Sep 30, 2024 | 2.07 Mn |
| Sep 30, 2024 | 2.07 Mn |